Trial intelligence / Profile preview

Carbetocin versus oxytocin for reducing postoperative blood loss after caesarean section in Nigeria

PACTR202201739991276Recruiting

Sponsor
OKWUCHUKWU ONYEOWUZONI
Start
Feb 2022
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised trial in postpartum hemorrhage (PPH) comparing Carbetocin arm with Oxytocin arm (2 arms). Primary endpoint: Postoperative blood loss. Started Feb 2022; status: recruiting.

02

Drugs

carbetocinoxytocin
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on PACTR202201739991276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202201739991276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call